Everyday Health beefs up lifestyle offering with EQAL buy

Share this article:
Everyday Health acquired EQAL, which manages digital media properties for consumer brands and celebrities, including Jennifer Lopez, Bethenny Frankel and Lauren Conrad.

The firm was founded by Miles Beckett and Greg Goodfried, the guys behind lonelygirl15, KateModern and Harpers Globe, boasts more than 40 media properties, including WalkWithWalgreens.com, Kraft's RealWomenofPhiladelphia.com and ToriSpelling.com. It will continue to be based in Los Angeles, under the leadership of Beckett and Goodfried, who will report to Everyday Health EVP and general manager for lifestyle Laura Klein in New York.

“Everyday Health has been focused on the growing lifestyle verticals for several years, and this acquisition expands our content and marketing opportunities further,” said CEO and cofounder Ben Wolin. “Co,bining Everyday Health's broad reach and existing portfolio with EQAL's expertise in paid and earned media solutions will provide marketers with an unparalleled solution for cutting-edge integrated marketing opportunities across multiple platforms.”

Financial terms of the deal were not disclosed.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...